Oncopatch
Boulder, US · Founded 2023 · Delaware corporation · 2 known investors
OncoPatch develops a non-invasive medical patch that delivers low-energy beta therapy to treat non-melanoma skin cancers, including basal and squamous cell carcinomas. The single-application treatment is administered in a physician's office and targets cancer cells while sparing healthy tissue.
BiotechMedical Devices
Founders & leadership
DW

David WesterlyCo-founder & CEO
QD

Quentin DiotCo-founder
FS
Frederic SarazinCo-founder
JZ

Jeramy ZimmermanCo-founder
BM
Bill MillerDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$418.8KraisedDec 2025 · 5 investors · OtherRule 506(b)
▶$418.8KraisedDec 2025 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Quentin DiotExecutive Officer, Promoter
- Frederic SarazinExecutive Officer, Director, Promoter
- David Clark WesterlyExecutive Officer, Director, Promoter
- Bill MillerDirector
- Jeramy ZimmermanExecutive Officer, Promoter
- Offering amount
- $2M
- Amount sold
- $418.8K
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.